IL2 and neoplasm: Prostaglandin E2, an unsaturated fatty acid secreted by tumor cells, suppresses T cell responses both indirectly by modulating inflammatory monocytes and directly by reducing T cell sensitivity to IL-2, thereby impairing their anti-tumor activity [128–130].